A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma | MicrobiomeTrials← Back to trialsNCT07428616
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-31Est. Completion: 2028-02-29
Enrollment target: 100 participants Locations- Exelixis Site #3, Miami, Florida, United States
- Exelixis Site #2, Houston, Texas, United States
- Exelixis Site #1, San Antonio, Texas, United States
Other microbiome trials you might be interested in
Sellar MassPituitray Tumor
The goal of this observational study is to learn about the clinical spectrum of sellar masses, aiming to understand the …
Sanaa, YemenCompleted Dec 1, 2025
Primary Brain TumorGliomaMeningiomaSchwannoma
In this proposal, the investigators introduce a novel, translational study to prospectively examine primary brain tumor …
San Diego, United StatesEst. completion Dec 2030
Recruiting
Objective
With this prospective natural experiment trial on neurofibromatosis type 2 (NF2) study, we hope to understand…